Randal W. Scott, CEO, In Vitae Corporation* at GENOMIC HEALTH INC (GHDX), sold 30,000 shares at $35.96 ($1.1M) on 2012-07-10, disclosed to the SEC on 2012-07-12.
Scheduled sale ($1.1M) by CEO, In Vitae Corporation* under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.96 | 14,800 | $532K | 50.1% |
| 2 | $36.65 | 200 | $7K | 0.7% |
| 3 | $34.79 | 14,700 | $511K | 48.2% |
| 4 | $35.52 | 300 | $11K | 1.0% |
| Total | $35.39 avg | 30,000 | $1.1M | 100% |
| Filing → |
| NVTA | SELL | 2019-02-27 | $573K | — | Filing → |
| NVTA | BUY | 2018-04-02 | $200K | — | Filing → |
| NVTA | BUY | 2016-11-22 | $400K | — | Filing → |